# Isomorphic Labs Targets $40B Valuation

> Isomorphic Labs, DeepMind's AI drug discovery spinout, aims for $40 billion valuation after May's $2.1 billion funding round.
- Title: Isomorphic Labs Targets $40B Valuation · Dealroom | Shortify
- Summary: Isomorphic Labs, DeepMind's AI drug discovery spinout, aims for $40 billion valuation after May's $2.1 billion funding round. Isomorphic Labs, a DeepMind…
- Keywords: isomorphic labs, deepmind, ai drug discovery, series c funding, valuation, drug development, startups, business, Isomorphic, Labs, Targets, 40B
- Source: Dealroom — https://dealroom.co/news/161156-deepmind-spinout-isomorphic-labs-eyes-40b-valuation-up-from-2-1b-round-i
- Published: 2026-10-09T12:39:00+00:00
- Read time: 1 min
- Topics: isomorphic labs, deepmind, ai drug discovery, series c funding, valuation, drug development, startups, business
## Isomorphic Labs
Isomorphic Labs, the Google DeepMind spinout applying AI to drug discovery, is in early talks to raise a Series C at a valuation of at least $40 billion.
## Funding Round Details
The financing has not closed, and neither the round size nor the investors have been reported.
## Market Context
A $40 billion valuation would rank among the largest in the sector, with AI in drug discovery estimated at $2.3 billion in 2025, growing to $13.8 billion by 2033.
## Key takeaway

Isomorphic Labs, a DeepMind spinout using AI for drug discovery, targets a $40 billion valuation following a $2.1 billion Series B round in May.